These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 1840764)

  • 1. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Hydroxytryptamine-receptor subtypes.
    Brodde OE
    Clin Physiol Biochem; 1990; 8 Suppl 3():19-27. PubMed ID: 2132174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
    Montgomery SA; Fineberg N
    Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serotonin receptor subtypes. Considerations on their physiological role and therapeutic prospects].
    Di Renzo G; Marino A
    Clin Ter; 1990 Apr; 133(1):3-7. PubMed ID: 2140742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.
    Pandey SC; Davis JM; Pandey GN
    J Psychiatry Neurosci; 1995 May; 20(3):215-25. PubMed ID: 7786883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor subtypes and affective disorders.
    Robinson DS
    Clin Neuropharmacol; 1993; 16 Suppl 3():S1-5. PubMed ID: 8131151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
    Hoyer D; Clarke DE; Fozard JR; Hartig PR; Martin GR; Mylecharane EJ; Saxena PR; Humphrey PP
    Pharmacol Rev; 1994 Jun; 46(2):157-203. PubMed ID: 7938165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of agonists and antagonists of some serotonin-receptor subtypes on memory and their modulation by the 5-HT-uptake inhibitor fluoxetine.
    Petkov VD; Kehayov R
    Acta Physiol Pharmacol Bulg; 1994; 20(3-4):83-90. PubMed ID: 7645408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys.
    May JA; McLaughlin MA; Sharif NA; Hellberg MR; Dean TR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):301-9. PubMed ID: 12676887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of serotonin in therapy of depression and related disorders.
    Fuller RW
    J Clin Psychiatry; 1991 May; 52 Suppl():52-7. PubMed ID: 1674251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of serotonin receptors.
    Göthert M; Schlicker E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S3-7. PubMed ID: 2446065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential value of 5-HT2 receptor antagonists in the treatment of dysthymic disorders].
    Sechter D; Bonin B; Bizouard P
    Encephale; 1992 Dec; 18 Spec No 5():753-4. PubMed ID: 1342678
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
    Gleeson S; Ahlers ST; Mansbach RS; Foust JM; Barrett JE
    J Pharmacol Exp Ther; 1989 Sep; 250(3):809-17. PubMed ID: 2476547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.